Pet Drug Reports

Ingredients

Active ingredient · pooled across combinations

Dextrose: adverse event reports, pooled

5 ingredient sets in reports · 1 FDA-approved application in the Green Book

402reports naming the ingredient, 1992–20260% of all reports · about 12 a year
40reports, 12 months to March 202652 in the 12 months before
89.9%classed serious, as reportedall reports: 38.6%
52.2%of reports concern dogscat 22.4%

Dextrose appears, alone or combined with other ingredients, in 402 reports in FDA's animal adverse event database (October 1992 to March 2026). The figures here pool all 5 ingredient sets that include it.

The Green Book lists 1 FDA-approved application containing it. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand.

40 reports arrived in the 12 months to March 2026, down 23% from 52 in the 12 months before. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. That is about 12 reports a year over its reporting history and 0% of all reports.

Pooled across every set, the terms listed most often are hypoglycaemia (32.6%), death (26.1%) and lethargy (25.1%). Many drugs combine several ingredients, and many reports list several drugs, so a term on this page may relate to any of them or to none.

Of reports that state seriousness, 89.9% were classed as serious (38.6% across the whole database); 49.5% record a death or euthanasia (6.4% overall). Ingredients used in older or sicker animals, or in anaesthesia and cancer care, carry higher shares for that reason alone.

Ingredient sets that include dextrose

Active ingredients recorded for the drugReportsShare of this page's reportsLatest 12 months
Dextrose29473.1%35
Dextrose + Sodium Chloride7518.7%5
Citric Acid + Dextrose + Glycine + Potassium Citrate + Potassium Phosphate + Sodium Chloride317.7%0
Dextrose + Erythromycin + Vitamin B1 + Vitamin B210.2%0
Citric Acid + Dextrose + Glycine + Potassium Phosphate + Sodium Chloride10.2%0

Ordered by report count. FDA states that these data "cannot be used to estimate the risk associated with the product or compare one drug or device product with another"; counts follow sales volume and years on the market. A report can list more than one set, so shares can add to more than 100%.

Signs listed in reports, pooled

share of dextrose reports listing the termall reports in the database

  1. Hypoglycaemia[low blood sugar]32.6%131
  2. Death26.1%105
  3. Lethargy[unusually tired or inactive]25.1%101
  4. Death by euthanasia[the animal was euthanized]23.6%95
  5. Vomiting19.4%78
  6. Other abnormal test result NOS[abnormal laboratory result, type not specified]17.2%69
  7. Elevated total bilirubin[bilirubin above the normal range]15.2%61
  8. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]13.9%56
  9. Containers, Damaged[a product quality report, not a sign in an animal]13.7%55
  10. Anorexia[not eating]13.2%53
  11. Not eating12.4%50
  12. Diarrhoea[diarrhea]12.2%49
  13. Hypokalaemia[low blood potassium]11.4%46
  14. Leucocytosis NOS[high white blood cell count]11.4%46
  15. Seizure NOS[seizure, type not specified]11.4%46
  16. Containers, Leaking[a product quality report, not a sign in an animal]11.2%45
  17. Elevated blood urea nitrogen (BUN)[a kidney value above the normal range]10.9%44
  18. Hyperphosphataemia[high blood phosphate]10.9%44
  19. Hyperglycaemia[high blood sugar]10.7%43
  20. Hypoalbuminaemia[low blood albumin]10.7%43
  21. Lateral recumbency[lying on the side, unable to rise]8.7%35
  22. Neutrophilia[high neutrophil count]8.5%34
  23. Hypothermia[low body temperature]8.2%33
  24. Fever8%32
  25. Anaemia NOS[low red blood cell count]7.7%31
  26. Elevated creatinine[a kidney value above the normal range]7.2%29
  27. Hyponatremia[low blood sodium]7.2%29

Pooled across every ingredient set and every report that names the ingredient. One report can list several terms and several drugs; a term here may relate to any of them or to none.

Monthly reports by species, five years

Dog84 · peak 7
Apr 2021: 1Jun 2021: 1Aug 2021: 2Oct 2021: 3Nov 2021: 1Dec 2021: 1Feb 2022: 1Mar 2022: 1Jul 2022: 1Sep 2022: 1Nov 2022: 1Apr 2023: 1May 2023: 2Jul 2023: 7Aug 2023: 1Oct 2023: 2Nov 2023: 3Dec 2023: 1Jan 2024: 3Mar 2024: 2Apr 2024: 1May 2024: 3Aug 2024: 5Oct 2024: 2Nov 2024: 2Dec 2024: 3Jan 2025: 6Feb 2025: 2Mar 2025: 4Apr 2025: 3May 2025: 4Jun 2025: 3Jul 2025: 2Oct 2025: 1Nov 2025: 1Jan 2026: 1Feb 2026: 3Mar 2026: 22022202320242025
Cat54 · peak 5
Nov 2021: 1Apr 2022: 1Jan 2023: 1Jun 2023: 2Oct 2023: 3Dec 2023: 2Jan 2024: 5Feb 2024: 1Mar 2024: 3Apr 2024: 3May 2024: 2Sep 2024: 2Oct 2024: 3Nov 2024: 5Dec 2024: 2Jan 2025: 2Feb 2025: 1Apr 2025: 1May 2025: 1Jun 2025: 1Jul 2025: 1Aug 2025: 2Sep 2025: 3Oct 2025: 1Jan 2026: 1Feb 2026: 42022202320242025
Horse0 · peak 1
2022202320242025
Other42 · peak 4
Apr 2021: 3May 2021: 2Jul 2021: 1Aug 2021: 1Sep 2021: 1Oct 2021: 1Jan 2022: 1Apr 2022: 1May 2022: 1Jun 2022: 1Jul 2022: 1Aug 2022: 1Sep 2022: 1Oct 2022: 1Nov 2022: 1Feb 2023: 2Mar 2023: 2Apr 2023: 1May 2023: 4Jun 2023: 1Jul 2023: 1Nov 2023: 1Feb 2024: 1Mar 2024: 2Jun 2024: 1Oct 2024: 2Nov 2024: 1Apr 2025: 2May 2025: 1Jul 2025: 1Aug 2025: 12022202320242025

By month of receipt; each panel has its own scale. The newest months are incomplete because FDA posts reports with a delay of three to six months.

027541992: 119921995: 11997: 11999: 319992000: 72001: 12002: 120022003: 12005: 12006: 420062007: 82008: 72009: 1020092010: 32012: 222013: 2820132014: 122015: 72016: 1620162017: 142018: 282019: 2020192020: 222021: 232022: 1520222023: 372024: 542025: 4420252026: 11

Outcomes, report types and ages

Outcome recorded in the report

Recovered/Normal8.5%34
Recovered with Sequela0%0
Ongoing13.2%53
Died26.6%107
Euthanized23.4%94
Outcome Unknown7.5%30

What kind of report it was

Safety issue73.1%294
Lack of expected effectiveness1.2%5
Both safety and lack of expected effectiveness4.5%18
Manufacturing or product defect21.1%85
Other0%0

Species

Dog52.2%210
Cat22.4%90
Cattle3%12
Human exposure0.2%1
Other0.2%1
Other Birds0.2%1

Age of the animal

Under 1 year20.6%83
1 to 3 years15.7%63
4 to 7 years12.4%50
8 to 11 years17.4%70
12 years and over9%36
Age not given24.9%100

Coloured bar: reports naming dextrose. Grey bar: all 1,357,245 reports. Outcomes are as stated by the reporter; FDA has not necessarily determined whether any product played a part.

In context

MeasureDextroseAll reports
Reports4021,357,245
Latest 12 months against the 12 before-23%-5%
Classed serious, of reports stating it89.9%38.6%
Death or euthanasia recorded, per 1,000 reports49563.8
Filed as lack of expected effectiveness (wholly or partly)5.7%23%

Shares of reports, not of animals treated: how many animals receive the ingredient is not public. Ingredients used in anaesthesia, cancer care or in old animals carry more serious outcomes in their reports for that reason alone.

FDA-approved products containing dextrose (Green Book)

Reference information, not report statistics. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The list below is the FDA Green Book as of 30 Sep 2026; nothing on this page says which of these products, if any, a report concerned.

Trade nameActive ingredientsSponsorApproved forApplication
Re-Sorb; VytrateCitric Acid, Dextrose, Glycine, Potassium Citrate, Potassium Phosphate, Sodium ChloridePhibro Animal Health Corp.CattleNADA 125-961

Species are the major species the Green Book search lists for the application ("—" where it lists another species or none). Approval dates are not part of the Green Book listing files and are not shown. Pioneer applications (NADA) come first, then generics (ANADA).

Questions about dextrose reports

How many FDA adverse event reports mention dextrose?

402 reports through March 2026, 40 of them in the latest 12 months, counting dextrose alone and in combinations.

Which brands do these reports concern?

That cannot be known from the public data. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The Green Book reference list on this page names approved products containing dextrose without any counts.

In which combinations is dextrose reported?

Dextrose (73.1% of these reports), Dextrose + Sodium Chloride (18.7% of these reports), Citric Acid + Dextrose + Glycine + Potassium Citrate + Potassium Phosphate + Sodium Chloride (7.7% of these reports), Dextrose + Erythromycin + Vitamin B1 + Vitamin B2 (0.2% of these reports) and Citric Acid + Dextrose + Glycine + Potassium Phosphate + Sodium Chloride (0.2% of these reports).

What reactions are reported for dextrose?

hypoglycaemia (32.6%), death (26.1%), lethargy (25.1%), death by euthanasia (23.6%) and vomiting (19.4%). Shares are of reports naming the ingredient; one report can list several terms.

Which animals are these reports about?

dog (52.2%), cat (22.4%) and cattle (3%).

Does a high count mean dextrose is a problem ingredient?

A count cannot show that. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources." Widely used ingredients collect more reports because more animals receive them.

How do I report a problem?

Call the drug company using the number on the label, or send Form FDA 1932a to FDA. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 30 Sep 2026. Ingredient names follow the Green Book; salts and forms are kept as FDA lists them. Drug entries are matched by the active ingredients their unmasked ingredient field discloses. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.